Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

Shares of Baxter International Inc. BAX slid 4.02% to $34.41 Wednesday, on what proved to be an all-around mixed trading ...

The FDA today issued a notice warning of a potential high-risk issue with certain Baxter Spectrum infusion pump systems.

Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Baxter International Inc. closed 20.10% short of its 52-week high of $44.01, which the company reached on March 8th.

Barclays analyst Matt Miksic maintained a Buy rating on Baxter International (BAX – Research Report) on March 7 and set a price target of ...

Goldman Sachs analysts added Baxter (BAX) to the firm’s US Conviction List as part of its monthly update. The firm expects a turnaround in ...

Baxter International’s largest manufacturing ... and led to the cancellation of some surgeries. The Deerfield-based company was forced to temporarily shutter its North Cove plant, in Marion ...

Top-line performance in the fourth quarter exceeded Baxter’s previously announced guidance, driven by better-than-expected sales in the company’s Medical Products & Therapies and ...

Investing.com -- Baxter International Inc. saw its shares jump 7.5% after the medical technology company reported fourth-quarter earnings and revenue that exceeded analyst expectations. The ...

Despite headwinds in its manufacturing capacity following Hurricane Helene, Baxter turned in 2% revenue growth in constant currency. Adjusted EPS of $0.58 in the fourth quarter was down 11% but ...